Understanding how the 30 mg vial fits into the broader picture helps you make better purchasing decisions based on your protocol stage and dose requirements
7 General Administration of Medical Services, Jeddah Medical Center, Jeddah, Saudi Arabia Correspondence: Yahya A Alzahrani, Drug Information Center, Department of Pharmacy, East Jeddah hospital, Ministry of health, Jeddah, 23816, Saudi Arabia, Tel +966557700178, Email [email protected] Background: The global increase in type 2 diabetes mellitus (DM2) and obesity presents a significant public health challenge, as these interconnected conditions contribute to severe complications, including cardiovascular disease, stroke, and certain cancers
(2) intervention (exposure) and comparator: SGLT2 inhibitor or GLP-1 receptor agonist monotherapy versus placebo or metformin as a first-line drug
In one large study involving people with obesity, participants using the combination lost about 20 percent of their body weight over 68 weeks
Authorization is product-specific, attaching to a particular brand, strength and dosage form
